bioMérieux Share Price Euronext Paris
Stocks
FR0010096479
Medical Equipment, Supplies & Distribution
OTC Markets Traded| Market Cap | 10.75B 11.8B 9.9B 9.01B 16.9B 1,092B 17.76B 121B 47.89B 597B 44.26B 43.33B 1,873B | P/E 2026 * |
21.3x | P/E 2027 * | 20.2x |
|---|---|---|---|---|---|
| Enterprise Value | 10.34B 11.35B 9.52B 8.66B 16.25B 1,051B 17.08B 116B 46.07B 574B 42.58B 41.68B 1,801B | EV / Sales 2026 * |
2.49x | EV / Sales 2027 * | 2.28x |
| Free-Float |
33.22% | Yield 2026 * |
1.16% | Yield 2027 * | 1.21% |
Last Transcript: bioMérieux
| 1 day | -0.27% |
| Manager | Title | Age | Since |
|---|---|---|---|
Pierre Boulud
CEO | Chief Executive Officer | 54 | 30/06/2023 |
| Director of Finance/CFO | 50 | 28/02/2018 | |
| Chief Tech/Sci/R&D Officer | - | 31/07/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 51 | 14/12/2017 | |
| Director/Board Member | 67 | 31/12/2004 | |
| Director/Board Member | 61 | 29/05/2012 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.27% | +1.25% | - | - | 11.8B | ||
| -0.84% | -5.09% | -19.60% | +1.07% | 178B | ||
| -0.67% | -2.84% | -1.25% | +27.12% | 122B | ||
| -0.98% | +0.12% | -15.82% | +5.56% | 118B | ||
| -1.24% | -4.25% | -42.94% | -1.34% | 88.1B | ||
| -0.63% | -5.55% | -7.27% | +70.54% | 64.71B | ||
| +0.05% | -2.41% | +10.41% | -9.90% | 57.96B | ||
| -1.95% | -3.98% | -6.85% | +41.55% | 53.28B | ||
| -2.91% | -4.35% | -0.97% | +38.45% | 47.8B | ||
| -1.64% | +1.50% | +1.30% | -2.04% | 35.65B | ||
| Average | -1.11% | -2.63% | -9.22% | +19.00% | 85B | |
| Weighted average by Cap. | -1.03% | -2.97% | -12.44% | +15.68% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.16B 4.57B 3.83B 3.49B 6.54B 423B 6.87B 46.64B 18.54B 231B 17.13B 16.77B 725B | 4.39B 4.82B 4.04B 3.68B 6.9B 446B 7.25B 49.18B 19.55B 244B 18.07B 17.69B 764B |
| Net income | 507M 557M 467M 425M 797M 51.54B 838M 5.69B 2.26B 28.15B 2.09B 2.04B 88.36B | 536M 589M 494M 449M 843M 54.5B 886M 6.01B 2.39B 29.77B 2.21B 2.16B 93.42B |
| Net Debt | -409M -449M -377M -343M -643M -41.6B -676M -4.59B -1.82B -22.72B -1.69B -1.65B -71.31B | -727M -799M -670M -610M -1.14B -73.96B -1.2B -8.16B -3.24B -40.4B -3B -2.93B -127B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.


















